T3I announces new Vice-President and Chief Financial Officer.

Ridgefield, CT. ------ September 18, 2000

Mr. Barry Ressler, Chairman and Chief Executive Officer of Triton Thalassic Technologies, Inc. (T3I) announced today that Mr. Steve Ward has joined T3I as Vice-President and Chief Financial Officer.

Prior to joining T3I, Mr. Ward was Senior Vice President -Administration for Sanofi-Synthelabo, one of the world's leading pharmaceutical and healthcare companies with over $5 billion in annual sales. Mr Ward's prior assignments in the Pharmaceutical industry were Executive Vice President of Sanofi, Inc, and increasingly responsible CFO positions located both in Europe and the U.S. He started his career at General Electric with assignments in Purchasing, Corporate Audit, and Financial Management positions. Mr. Ressler commented, "Steve's extensive experience at public corporations in financial and operations management will be an important addition to T3I’s management team to support our targeted FY-2001 sales growth and our long term strategic goals". Mr. Ressler went on to say, "Steve is joining T3I at a critical time in the commercialization of our FASTAC technology and product line which in addition to the treatment of industrial fluids and marine fouling, includes paper industry, food processing and medical applications.

Mr. Ward received his BA in Economics from Colby College and his MBA-Finance from the University of Utah. In addition, he participated in General Electric's Management Institute and Financial Management Program. Steve and his wife Sandy have 3 children and reside in Darien, CT

The company welcomes prospective customers with fluid contamination questions and challenges to use our convenient inquiry response form.